Nephrology
Cohort Study | Assessment of Cystatin C level for cardiovascular and mortality risk stratification in adults with mild CKD.
1 Nov, 2022 | 11:56h | UTCCommentary: Cystatin C Is a Better Marker of Cardiovascular Risk in CKD – Renal & Urology News
Commentary on Twitter
#CystatinC-estimated GFR may help identify which patients with creatinine-estimated GFR of 45-59 are at high risk of future cardiovascular disease from their mild CKD. #OAResearch #OAWeek https://t.co/2U6NNPMPS2
— JAMA Network Open (@JAMANetworkOpen) October 28, 2022
IPNA recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.
28 Oct, 2022 | 13:20h | UTC
Commentary on Twitter
Just published! IPNA guideline for management of steroid-sensitive nephrotic syndrome! @Ped_Nephhttps://t.co/KlGORgQtMa pic.twitter.com/kME16MCtXY
— 𝐉𝐨𝐬𝐞𝐩𝐡 𝐅𝐥𝐲𝐧𝐧, 𝐌𝐃 (@drjosflynn) October 22, 2022
Under a http://creativecommons.org/licenses/by/4.0/ License
Study commentary | From the management of altitude sickness to congestion in acute HF: a new season for acetazolamide?
27 Oct, 2022 | 12:27h | UTCFrom the management of altitude sickness to treatment of congestion in acute heart failure: a new season for acetazolamide? – European Heart Journal (free for a limited period)
Original study: RCT | Acetazolamide resulted in faster decongestion in patients with acute decompensated heart failure with volume overload.
KDIGO 2022 Clinical practice guideline for diabetes management in chronic kidney disease.
24 Oct, 2022 | 14:16h | UTCRelated: ADA/KDIGO Consensus Report | Diabetes management in chronic kidney disease.
AHA Scientific Statement | Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates.
24 Oct, 2022 | 14:11h | UTCTop Things to Know: Emerging Evidence on Coronary Heart Disease (CHD) Screening in Kidney and Liver Transplantation Candidates – American Heart Association
Brief Review | Management of oliguria.
21 Oct, 2022 | 13:04h | UTCManagement of oliguria – Intensive Care Medicine (if the link is paywalled, try this one)
Commentary on Twitter
Oliguria relatively frequent in #ICU & perioperative setting, but most episodes not followed by #AKI:
➡️ physiological vs pathological
➡️ impact
➡️ management
Even if clinically important, interpret isolated oliguria with caution, considering context.
🗞️ https://t.co/xVs2Wa3mgB pic.twitter.com/4pX4UcHY1R— Intensive Care Medicine (@yourICM) October 21, 2022
Clinical practice update for management of acute kidney injury associated with cardiac surgery.
20 Oct, 2022 | 12:31h | UTCSociety of Cardiovascular Anesthesiologists Clinical Practice Update for Management of Acute Kidney Injury Associated With Cardiac Surgery – Anesthesia & Analgesia (free for a limited period)
Commentary on Twitter
The @scahq Clinical Practice Update for Management of Acute Kidney Injury Associated With Cardiac Surgery https://t.co/miFP5MkbnL @iars360
Potential renoprotective benefit:
❤️Goal-directed oxygen delivery on CPB
❤️KDIGO
❤️The use of vasopressin in vasoplegic shock pic.twitter.com/S9O2RtIhIr— Anesthesia&Analgesia (@IARS_Journals) October 13, 2022
M-A | Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes.
19 Oct, 2022 | 14:11h | UTC
Position Statement | Changing the name of diabetes insipidus.
18 Oct, 2022 | 12:50h | UTC
Position Statement | Chronic kidney disease as cardiovascular risk factor in routine clinical practice.
14 Oct, 2022 | 14:17h | UTC
Review | Point-of-care ultrasound in pediatric nephrology.
14 Oct, 2022 | 14:03h | UTCPoint-of-care ultrasound in pediatric nephrology – Pediatric Nephrology (if the link is paywalled, try this one)
Cohort Study | Incidence, predictors and clinical implications of new renal impairment following percutaneous coronary intervention.
13 Oct, 2022 | 13:42h | UTC
Commentary on Twitter
https://twitter.com/Open_HeartBMJ/status/1580211725151784962
Review | Acid-base disorders in the critically ill patient.
11 Oct, 2022 | 13:41h | UTC
Perspective | Hydrochlorothiazide vs. chlorthalidone – what is the difference?
11 Oct, 2022 | 13:40h | UTCHydrochlorothiazide Versus Chlorthalidone–What is the Difference? – Circulation (free for a limited period)
Related:
Meta-analysis: Chlorthalidone vs. hydrochlorothiazide
Commentary on Twitter
There are big differences among diuretics even within the same class. So let us rethink the class effect. https://t.co/ruE4IYeFf2. Here I discuss what we know about HCTZ vs CTD. pic.twitter.com/cyljdi04v9
— Rajiv Agarwal MD, MS (@AgarwalRajivMD) October 8, 2022
Review | Hyponatremia in the emergency department.
7 Oct, 2022 | 14:20h | UTCHyponatremia in the emergency department – The American Journal of Emergency Medicine
Related:
Acute and Chronic Hyponatremia – Frontiers in Medicine
Podcast: Hyponatremia deconstructed
Guidelines for the Management of Exercise-Associated Hyponatremia
Diabetic kidney disease back in focus: management field guide for health care professionals in the 21st century.
7 Oct, 2022 | 14:08h | UTCRelated: ADA/KDIGO Consensus Report | Diabetes management in chronic kidney disease.
Review | Facing the challenge of drug-induced acute interstitial nephritis.
6 Oct, 2022 | 13:37h | UTCFacing the Challenge of Drug-Induced Acute Interstitial Nephritis – Nephron
ADA/KDIGO Consensus Report | Diabetes management in chronic kidney disease.
5 Oct, 2022 | 13:59h | UTCNews Release: NEWS RELEASE: ADA & KDIGO Release Joint Consensus Report on Diabetes Management in CKD
Brief Review | How do we maximize diuresis in acute decompensated heart failure?
5 Oct, 2022 | 13:51h | UTC
Consensus Recommendations | Priority activities to address acute kidney injury in children.
3 Oct, 2022 | 14:01h | UTCInvited Commentary: Highlights of Consensus-Based Recommendations for Acute Kidney Injury in Children – JAMA Network Open
Commentary on Twitter
https://twitter.com/JAMANetworkOpen/status/1575893237201600517
Review | Acute kidney injury in patients with liver disease.
3 Oct, 2022 | 13:56h | UTC
Commentary on Twitter
AKI is commonly encountered in patients with decompensated cirrhosis, and it is associated with unfavorable outcomes. This article discusses tailoring management of AKI in patients with liver disease to the specific underlying etiology https://t.co/UVEeYBL8ff@VelezNephHepato pic.twitter.com/V5J8hBQyuw
— CJASN (@CJASN) September 27, 2022
Consensus Paper | Renal effects of guideline-directed medical therapies in heart failure.
27 Sep, 2022 | 13:13h | UTC
Brief Review | Everything you need to know about deresuscitation.
21 Sep, 2022 | 13:19h | UTCEverything you need to know about deresuscitation – Intensive Care Medicine
Commentary on Twitter
Fluid administration among most common interventions in #ICU… but high potential for harm! Here everything you need to know about deresuscitation
☔️ Why deresuscitation?
☔️ What is it?
☔️ When to start/stop?
☔️ How to deresuscitate?
☔️ So what's next?
🖇️ https://t.co/Qmvm3aOQPA pic.twitter.com/u3ZfNMa2W7— Intensive Care Medicine (@yourICM) August 7, 2022
Sodium and water perturbations in patients who had an acute stroke: clinical relevance and management strategies for the neurologist.
21 Sep, 2022 | 13:06h | UTC
Long-term follow-up of a RCT | Outcomes after catheter-based renal artery denervation for resistant hypertension.
20 Sep, 2022 | 13:33h | UTCLong-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial – The Lancet (free registration required)
Commentary: SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss – TCTMD
Original Study: A Controlled Trial of Renal Denervation for Resistant Hypertension – New England Journal of Medicine